The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong: Accuracy amidst ambiguity

Clinical Infectious Diseases

Volumn 53, Issue 1, 2011, Pages 100-102

  Kok, Jen ^a   Dwyer, Dominic E ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; GEOGRAPHIC DISTRIBUTION; HEMAGGLUTINATION INHIBITION; HONG KONG; HUMAN; INFLUENZA VIRUS A H1N1; LETTER; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SEROCONVERSION; VIRUS NEUTRALIZATION;

ANTIBODIES, VIRAL; DISEASE OUTBREAKS; HUMANS; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN;

EID: 79958845507     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir281     Document Type: Letter

References (11)

1. Wu JT, Ma ES, Lee CK, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010; 51:1184-91.
2. Kok J, Tudo K, Blyth CC, et al. Pandemic (H1N1) 2009 influenza virus seroconversion rates in HIV-infected individuals. J Acquir Immune Defic Syndr 2011; 56:91-4.
3. Miller E, Hoschler K, Hardelid P, et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010; 375:1100-8.
4. Bandaranayake D, Huang QS, Bissielo A, et al. Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One 2010; 5:e13211. doi: 10.1371/journal.- pone.0013211.
5. Gilbert GL, Cretikos MA, Hueston L, et al. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One 2010; 5:e12562. doi: 10.1371/journal.pone. 0012562.
6. McVernon J, Laurie K, Nolan T, et al. Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October-December 2009. Euro Surveill 2010; 15:19678.
7. Chen MI, Lee VJ, Lim W, et al. 2009 Influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 2010; 303:1383-91.
8. Adamson WE, Maddi S, Robertson C, et al. 2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak. Euro Surveill 2010; 15:19590.
9. Aho M, Lyytikänen O, Nyholm JE, et al. Outbreak of 2009 pandemic influenza A(H1N1) in a Finnish garrison - a serological survey. Euro Surveill 2010; 15:19709.
10. Waalen K, Kilander A, Dudman SG, et al. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill 2010; 15:19633.
11. Bachmann MF, Ecabert B, Kopf M. Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitro. J Immun Methods 1999; 225:105-11. (Pubitemid 29276941)